Evidence-based evaluation and management of chronic urticaria in children

Kristine B Zitelli1, Kelly M Cordoro2,3

  • 1Psoriasis Treatment Center.

Pediatric Dermatology
|October 5, 2011
PubMed

Insights

Chronic urticaria (CU) affects many children, often with unknown causes. This study provides a framework to help categorize, evaluate, and treat pediatric chronic urticaria for better patient outcomes.

Area of Science:

  • Pediatric Dermatology
  • Immunology
  • Allergy

Background:

  • Urticaria affects a significant portion of the population.
  • Chronic urticaria (CU) in children can severely impact quality of life.
  • The exact causes of pediatric CU are often unidentified, leading to a designation of chronic idiopathic urticaria.

Purpose of the Study:

  • To develop a conceptual framework for the categorization, clinical evaluation, and treatment of chronic urticaria in children.
  • To address the clinical complexities and literature confusion surrounding pediatric CU.
  • To provide evidence-based guidance for managing chronic urticaria in pediatric populations.

Main Methods:

  • Literature review and synthesis of cumulative evidence.
  • Development of a conceptual framework.
  • Analysis of proposed causes and triggers for pediatric CU.

Main Results:

  • Identified numerous proposed causes and triggers for pediatric CU, including infections, allergens, medications, physical factors, and autoimmune disease.
  • Highlighted the frequent lack of identifiable etiology, resulting in 'chronic idiopathic urticaria' diagnoses.
  • Established a framework to aid in the systematic approach to pediatric CU.

Conclusions:

  • A structured approach is needed to manage the complexities of pediatric chronic urticaria.
  • The proposed framework can assist clinicians in evaluating and treating children with CU.
  • Further research may elucidate the specific etiologies in cases currently designated as idiopathic.

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...